Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease
- PMID: 10355517
- DOI: 10.1046/j.1440-1746.1999.01888.x
Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease
Abstract
Background: Diarrhoea is an important feature of the carcinoid syndrome, and various agents which may be released from carcinoid tumours have been considered to contribute pathophysiologically. The aim of the present study was to determine luminal concentrations of possible chemical mediators in an uninvolved small intestinal segment using a two-balloon six-channel tube in nine patients with malignant midgut carcinoid disease.
Methods: All patients were treated with interferon and/or octreotide to alleviate the most severe flush. Ion transport was measured during luminal perfusion and luminal perfusate concentrations of calcitonin gene-related peptide, neurotensin, prostaglandin E (PGE)2, neuropeptide Y, somatostatin, vasoactive intestinal polypeptide, substance P and other tachykinins (neurokinin A, neurokinin B, neuropeptide K, eledoisin) were determined by separate assays.
Results: Carcinoid patients showed decreased absorption of Cl-, Na+, K+ and water and increased luminal content of non-substance P tachykinins to 424.5 fmol/cm per h, compared with 255.5 fmol/cm per h in control subjects. There were also increased luminal concentrations of PGE2, commonly claimed as a more general mediator of diarrhoea.
Conclusions: The observed increase in intestinal tachykinins may involve extended activity from tachykinin-containing intrinsic neurones in the enteric nervous system, contributing to enhanced intestinal motility and secretory diarrhoea in patients with carcinoid syndrome.
Similar articles
-
Tachykinin production by carcinoid tumours in culture.Eur J Cancer Clin Oncol. 1987 Jun;23(6):689-95. doi: 10.1016/0277-5379(87)90264-1. Eur J Cancer Clin Oncol. 1987. PMID: 3477459
-
Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.Eur J Clin Pharmacol. 1989;36(2):133-7. doi: 10.1007/BF00609184. Eur J Clin Pharmacol. 1989. PMID: 2470592
-
Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.Scand J Clin Lab Invest. 1995 Dec;55(8):679-89. doi: 10.3109/00365519509075398. Scand J Clin Lab Invest. 1995. PMID: 8903838
-
Carcinoids and carcinoid syndrome.Am J Med. 1987 May 29;82(5B):4-16. doi: 10.1016/0002-9343(87)90422-0. Am J Med. 1987. PMID: 2884878 Review. No abstract available.
-
Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):705-15. doi: 10.1016/j.bpg.2005.05.007. Best Pract Res Clin Gastroenterol. 2005. PMID: 16253895 Review.
Cited by
-
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.Endocr Rev. 2024 May 7;45(3):351-360. doi: 10.1210/endrev/bnad035. Endocr Rev. 2024. PMID: 38038364 Free PMC article.
-
Tachykinin NK(2) receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study.Br J Pharmacol. 2001 Aug;133(7):1107-13. doi: 10.1038/sj.bjp.0704164. Br J Pharmacol. 2001. PMID: 11487522 Free PMC article.
-
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.BMC Genomics. 2014 Jul 15;15(1):595. doi: 10.1186/1471-2164-15-595. BMC Genomics. 2014. PMID: 25023465 Free PMC article.
-
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.Br J Pharmacol. 2004 Apr;141(8):1249-63. doi: 10.1038/sj.bjp.0705751. Epub 2004 Mar 22. Br J Pharmacol. 2004. PMID: 15037522 Free PMC article. Review.
-
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.Cancers (Basel). 2023 Mar 9;15(6):1694. doi: 10.3390/cancers15061694. Cancers (Basel). 2023. PMID: 36980580 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical